281
Views
19
CrossRef citations to date
0
Altmetric
Research Articles

Preparation and in vitro/in vivo evaluation of 6-Gingerol TPGS/PEG-PCL polymeric micelles

, , , , , , ORCID Icon & show all
Pages 1-8 | Received 14 Aug 2018, Accepted 04 Dec 2018, Published online: 12 Nov 2019

References

  • Abdullah GZ, Abdulkarim MF, Chitneni M, Mutee AF, Ameer OZ, Salman IM, Noor AM. 2011. Preparation and in vitro evaluation of mebeverine HCl colon-targeted drug delivery system. Pharm Dev Technol. 16:331–342.
  • Abolaji AO, Ojo M, Afolabi TT, Arowoogun MD, Nwawolor D, Farombi EO. 2017. Protective properties of 6-gingerol-rich fraction from Zingiber officinale (Ginger) on chlorpyrifos-induced oxidative damage and inflammation in the brain, ovary and uterus of rats. Chem Biol Interact. 270:15–23.
  • Cao X, Deng W, Fu M, Zhu Y, Liu H, Wang L, Zeng J, Wei Y, Xu X, Yu J. 2013. Seventy-two-hour release formulation of the poorly soluble drug silybin based on porous silica nanoparticles: in vitro release kinetics and in vitro/in vivo correlations in beagle dogs. Eur J Pharm Sci. 48:64–71.
  • Chakraborty D, Mukherjee A, Sikdar S, Paul A, Ghosh S, Khuda-Bukhsh AR. 2012. [6]-Gingerol isolated from ginger attenuates sodium arsenite induced oxidative stress and plays a corrective role in improving insulin signaling in mice. Toxicol Lett. 210:34–43.
  • Cheng X, Yan H, Jia X, Zhang Z. 2016. Preparation and in vivo/in vitro evaluation of formononetin phospholipid/vitamin E TPGS micelles. J Drug Target. 24:161–168.
  • Chu C, Tong SS, Xu Y, Wang L, Fu M, Ge YR, Yu JN, Xu XM. 2011. Proliposomes for oral delivery of dehydrosilymarin: preparation and evaluation in vitro and in vivo. Acta Pharmacol Sin. 32:973–980.
  • Cuong NV, Jiang JL, Li YL, Chen JR, Jwo SC, Hsieh MF. 2010. Doxorubicin-loaded PEG-PCL-PEG micelle using xenograft model of nude mice: effect of multiple administration of micelle on the suppression of human breast cancer. Cancers (Basel). 3:61–78.
  • Duan Y, Zhang B, Chu L, Tong HH, Liu W, Zhai G. 2016. Evaluation in vitro and in vivo of curcumin-loaded mPEG-PLA/TPGS mixed micelles for oral administration. Colloids Surf B Biointerfaces. 141:345–354.
  • Dugasani S, Pichika MR, Nadarajah VD, Balijepalli MK, Tandra S, Korlakunta JN. 2010. Comparative antioxidant and anti-inflammatory effects of [6]-gingerol, [8]-gingerol, [10]-gingerol and [6]-shogaol. J Ethnopharmacol. 127:515–520.
  • Feng Y, Sun C, Yuan Y, Zhu Y, Wan J, Firempong CK, Omari-Siaw E, Xu Y, Pu Z, Yu J, et al. 2016. Enhanced oral bioavailability and in vivo antioxidant activity of chlorogenic acid via liposomal formulation. Int J Pharm. 501:342–349.
  • Gao K, Jiang X. 2006. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Int J Pharm. 310:213–219.
  • Gauthier ML, Beaudry F, Vachon P. 2013. Intrathecal [6]-gingerol administration alleviates peripherally induced neuropathic pain in male Sprague-Dawley rats. Phytother Res. 27:1251–1254.
  • Gong C, Shi S, Dong P, Kan B, Gou M, Wang X, Li X, Luo F, Zhao X, Wei Y, et al. 2009. Synthesis and characterization of PEG-PCL-PEG thermosensitive hydrogel. Int J Pharm. 365:89–99.
  • Guo Y, Luo J, Tan S, Otieno BO, Zhang Z. 2013. The applications of vitamin E TPGS in drug delivery. Eur J Pharm Sci. 49:175–186.
  • Halawany AME, Sayed NSE, Abdallah HM, Dine RSE. 2017. Protective effects of gingerol on streptozotocin-induced sporadic Alzheimer’s disease: emphasis on inhibition of β-amyloid, COX-2, alpha-, beta - secretases and APH1a. Sci Rep. 7:2902.
  • He W, Hu X, Jiang W, Liu R, Zhang D, Zhang J, Li Z, Luan Y. 2017. Rational design of a new self-codelivery system from redox-sensitive camptothecin-cytarabine conjugate assembly for effectively synergistic anticancer therapy. Adv Healthc Mater. 6: 1700829.
  • Hou J, Sun E, Sun C, Wang J, Yang L, Jia XB, Zhang ZH. 2016. Improved oral bioavailability and anticancer efficacy on breast cancer of paclitaxel via Novel Soluplus(®)-Solutol(®) HS15 binary mixed micelles system. Int J Pharm. 512:186–193.
  • Hou J, Sun E, Zhang ZH, Wang J, Yang L, Cui L, Ke ZC, Tan XB, Jia XB, Lv H. 2017. Improved oral absorption and anti-lung cancer activity of paclitaxel-loaded mixed micelles. Drug Deliv. 24:261–269.
  • Hou J, Wang J, Sun E, Yang L, Yan HM, Jia XB, Zhang ZH. 2016. Preparation and evaluation of icariside II-loaded binary mixed micelles using Solutol HS15 and Pluronic F127 as carriers. Drug Deliv. 23:3248–3256.
  • Hu M, Zhang J, Ding R, Fu Y, Gong T, Zhang Z. 2016. Improved oral bioavailability and therapeutic efficacy of dabigatran etexilate via Soluplus(®)-TPGS binary mixed micelles system. Drug Develop Commun. 43:687–697.
  • Hu X, Liu R, Zhang D, Zhang J, Li Z, Luan Y. 2018. Rational design of an amphiphilic chlorambucil prodrug realizing self-assembled micelles for efficient anticancer therapy. Acs Biomater Sci Eng. 4:973–980.
  • Jaapar SZS, Iwai Y, Morad NA. 2014. Effect of co-solvent on the solubility of ginger bioactive compounds in water using COSMO-RS calculations. AMM. 624:174–178.
  • Jeong JK, Moon MH, Park YG, Lee JH, Lee YJ, Seol JW, Park SY. 2013. Gingerol-induced hypoxia-inducible factor 1 alpha inhibits human prion peptide-mediated neurotoxicity. Phytother Res. 27:1185–1192.
  • Joshi H, Parle M. 2006. Evaluation of antiamnesic potentials of [6]-gingerol and phyllanthin in mice. Natural Products. 2:109–117.
  • Kim CY, Seo Y, Lee C, Park GH, Jang JH. 2018. Neuroprotective effect and molecular mechanism of [6]-gingerol against scopolamine-induced amnesia in C57BL/6 mice. Evid Based Complement Alternat Med. 2018:8941564.
  • Kim EC, Min JK, Kim TY, Lee SJ, Yang HO, Han S, Kim YM, Kwon YG. 2005. [6]-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo. Biochem Biophys Res Commun. 335:300–308.
  • Lee HS, Seo EY, Kang NE, Kim WK. 2008. [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells. J Nutr Biochem. 19:313–319.
  • Liao YR, Leu YL, Chan YY, Kuo PC, Wu TS. 2012. Anti-platelet aggregation and vasorelaxing effects of the constituents of the rhizomes of Zingiber officinale. Molecules. 17:8928–8937.
  • Liu J, Li H, Chen D, Jin X, Zhao X, Zhang C, Ping Q. 2011. In vivo evaluation of novel chitosan graft polymeric micelles for delivery of paclitaxel. Drug Deliv. 18:181–189.
  • Liu SQ, Tong YW, Yang YY. 2005. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions. Biomaterials. 26:5064–5074.
  • Masuda Y, Kikuzaki H, Hisamoto M, Nakatani N. 2004. Antioxidant properties of gingerol related compounds from ginger. Biofactors. 21:293–296.
  • Matsumoto R, Satoh H, Ueda M. 2016. Production of 5-O-α-glucosylgingerol via glucosylation of 6-gingerol by Ensifer sp. M-26. J Mol Catal B Enzym. 133:S200–S203.
  • Mei L, Zhang Z, Feng SS. 2013. PLA–TPGS nanoparticle formulation realized 91.3% oral bioavailability of docetaxel in vivo. J Control Release. 172:e55.
  • Meng X, Liu J, Yu X, Li J, Lu X, Shen T. 2017. Pluronic F127 and D-α-tocopheryl polyethylene glycol succinate (tpgs) mixed micelles for targeting drug delivery across the blood brain barrier. Sci Rep. 7:2964.
  • Munyendo WL, Zhang Z, Abbad S, Waddad AY, Lv H, Baraza LD, Zhou J. 2013. Micelles of TPGS modified apigenin phospholipid complex for oral administration: preparation, in vitro and in vivo evaluation. J Biomed Nanotechnol. 9:2034.
  • Muthu M, Kulkarni S, Liu Y, Feng S. 2012. Development of docetaxel-loaded vitamin E TPGS micelles: formulation optimization, effects on brain cancer cells and biodistribution in rats. Nanomedicine (Lond). 7:353–364.
  • Muthu MS, Kulkarni SA, Xiong J, Feng SS. 2011. Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. Int J Pharm. 421:332–340.
  • Omari-Siaw E, Wang Q, Sun C, Gu Z, Zhu Y, Cao X, Firempong CK, Agyare R, Xu X, Yu J. 2016. Tissue distribution and enhanced in vivo anti-hyperlipidemic-antioxidant effects of perillaldehyde-loaded liposomal nanoformulation against Poloxamer 407-induced hyperlipidemia. Int J Pharm. 513:68–77.
  • Omari-Siaw E, Zhu Y, Wang H, Peng W, Firempong CK, Wang YW, Cao X, Deng W, Yu J, Xu X. 2016. Hypolipidemic potential of perillaldehyde-loaded self-nanoemulsifying delivery system in high-fat diet induced hyperlipidemic mice: Formulation, in vitro and in vivo evaluation. Eur J Pharm Sci. 85:112–122.
  • Peng W, Jiang XY, Zhu Y, Omari-Siaw E, Deng WW, Yu JN, Xu XM, Zhang WM. 2015. Oral delivery of capsaicin using MPEG-PCL nanoparticles. Acta Pharmacol Sin. 36:139–148.
  • Pertz HH, Lehmann J, Roth-Ehrang R, Elz S. 2011. Effects of ginger constituents on the gastrointestinal tract: role of cholinergic M3 and serotonergic 5-HT3 and 5-HT4 receptors. Planta Med. 77:973–978.
  • Shi C, Zhang Z, Wang F, Luan Y. 2018. Active-targeting docetaxel-loaded mixed micelles for enhancing antitumor efficacy. J Mol Liq. 264:172–178.
  • Singh MP, Singh A, Alam G, Dhaneshwar V, Patel R, Datt N. 2012. Development and evaluation of polymeric microsphers of 6-gingerol for the treatment of peptic ulcer. J Pharm Res.
  • Sonali AP, Singh RP, Rajesh CV, Singh S, Vijayakumar MR, Pandey BL, Muthu MS. 2015. Transferrin receptor-targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats. Drug Deliv. 23:1788–1798.
  • Srivastava KC, Mustafa T. 1989. Ginger (Zingiber officinale) and rheumatic disorders. Med Hypotheses. 29:25–28.
  • Srivastava KC, Mustafa T. 1992. Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders. Med Hypotheses. 39:342–348.
  • Sun C, Yuan Y, Omari-Siaw E, Tong S, Zhu Y, Wang Q, Wang Y, Wei Q, Yu J, Xu X. 2017. An efficient HPLC method for determination of syringic acid liposome in rats plasma and mice tissues: pharmacokinetic and biodistribution application. Curr Pharm Anal. 14.
  • Syed Jaapar SZ, Morad NA, Iwai Y, Md. Sarip MS, Yunus MAC, Yusuff YAM. 2015. Estimation of ginger bioactive compound solubilities in hot compressed water and enhancement with entrainer. Fluid Phase Equilibria. 393:40–47.
  • Tao W, Zeng X, Liu T, Wang Z, Xiong Q, Ouyang C, Huang L, Mei L. 2013. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy. Acta Biomater. 9:8910–8920.
  • Tao W, Zhang J, Zeng X, Liu D, Liu G, Zhu X, Liu Y, Yu Q, Huang L, Mei L. 2015. Blended nanoparticle system based on miscible structurally similar polymers: a safe, simple, targeted, and surprisingly high efficiency vehicle for cancer therapy. Adv Healthc Mater. 4:1203–1214.
  • Tzeng TF, Chang CJ, Liu IM. 2014. 6-gingerol inhibits rosiglitazone-induced adipogenesis in 3T3-L1 adipocytes. Phytother Res. 28:187–192.
  • Wang L, Peng M, Zhu Y, Tong SS, Cao X, Xu XM, Yu JN. 2014. Preparation of pluronic/bile salt/phospholipid mixed micelles as drug solubility enhancer and study the effect of the PPO block size on the solubility of pyrene. Iran J Pharm Res. 13:1157–1163.
  • Wang Q, Wei Q, Yang Q, Cao X, Li Q, Shi F, Tong SS, Feng C, Yu Q, Yu J, et al. 2018. A novel formulation of [6]-gingerol: proliposomes with enhanced oral bioavailability and antitumor effect. Int J Pharm. 535:308–315.
  • Xu Y, Wang Q, Feng Y, Firempong CK, Zhu Y, Omari-Siaw E, Zheng Y, Pu Z, Xu X, Yu J. 2016. Enhanced oral bioavailability of [6]-Gingerol-SMEDDS: preparation, in vitro and in vivo evaluation. J Funct Foods. 27:703–710.
  • Yang L, Xin J, Zhang Z, Yan H, Wang J, Sun E, Hou J, Jia X, Lv H. 2016. TPGS-modified liposomes for the delivery of ginsenoside compound K against non-small cell lung cancer: formulation design and its evaluation in vitro and in vivo. J Pharm Pharmacol. 68:1109–1118.
  • Yang L, Zhang Z, Hou J, Jin X, Ke Z, Liu D, Du M, Jia X, Lv H. 2017. Targeted delivery of ginsenoside compound K using TPGS/PEG-PCL mixed micelles for effective treatment of lung cancer. IJN. 12:7653–7667.
  • Young HY, Luo YL, Cheng HY, Hsieh WC, Liao JC, Peng WH. 2005. Analgesic and anti-inflammatory activities of [6]-gingerol. J Ethnopharmacol. 96:207–210.
  • Yu A, Lv J, Yuan F, Xia Z, Fan K, Chen G, Ren J, Lin C, Wei S, Yang F. 2017. mPEG-PLA/TPGS mixed micelles via intranasal administration improved the bioavailability of lamotrigine in the hippocampus. Int J Nanomedicine. 12:8353–8362.
  • Zhu H, Chen H, Zeng X, Wang Z, Zhang X, Wu Y, Gao Y, Zhang J, Liu K, Liu R, et al. 2014. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance. Biomaterials. 35:2391–2400.
  • Zhu J, Wang Q, Li H, Zhang H, Zhu Y, Omari-Siaw E, Sun C, Wei Q, Deng W, Yu J, et al. 2018. Galangin-loaded, liver targeting liposomes: optimization and hepatoprotective efficacy. J Drug Deliv Sci Technol. 46:339–347.
  • Zhu Y, Wang M, Zhang J, Peng W, Firempong CK, Deng W, Wang Q, Wang S, Shi F, Yu J, et al. 2015. Improved oral bioavailability of capsaicin via liposomal nanoformulation: preparation, in vitro drug release and pharmacokinetics in rats. Arch Pharm Res. 38:512–521.
  • Zhu Y, Wang M, Zhang Y, Zeng J, Omari-Siaw E, Yu J, Xu X. 2016. In vitro release and bioavailability of silybin from micelle-templated porous calcium phosphate microparticles. AAPS PharmSciTech. 17:1232–1239.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.